Kaige Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kaige Chen has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Jiayang Wang
Department of Radiology, Harbin Medical University, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
5 shared publications - Wei Meng
Department of Radiology, Harbin Medical University, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
5 shared publications - Ping Wang
Department of Radiology, Harbin Medical University, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China; Department of Radiology, Beijing Jishuitan Hospital, Capital Medical University, Beijing 100035, China
4 shared publications - Xiaolong Yang
Department of Radiology, Harbin Medical University, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
4 shared publications Yingjie Li
Department of Radiology, Harbin Medical University, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
4 shared publications- Huiting Zhang
Department of Radiology, Harbin Medical University, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
3 shared publications
Latest Publications
- 10 August 2026
- Published by Elsevier in Academic Radiology
- Vol. 33 (11) , 4877-4889
Habitat-Based Radiomics Model of Pretreatment CT to Predict Pathological Response of Esophageal Squamous Cell Carcinoma to Neoadjuvant Chemoimmunotherapy: A Multicenter Prospective Study
- 10 August 2026
- Published by Elsevier in Academic Radiology
- Vol. 33 (11) , 4877-4889
Habitat-Based Radiomics Model of Pretreatment CT to Predict Pathological Response of Esophageal Squamous Cell Carcinoma to Neoadjuvant Chemoimmunotherapy: A Multicenter Prospective Study
- Open Access
- 9 December 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (4) , 9213-9224
Machine learning-based quantitative prediction of spread through air spaces in primary lung adenocarcinoma using intratumoral heterogeneity scores
Background: Spread through air spaces (STAS) is a distinct, aggressive pattern of primary lung adenocarcinoma (LUAD) that affects both prognosis and treatment strategies for patients. This study aimed to quantify intratumoral heterogeneity (ITH) and integrate the quantitative metrics with intratumoral-peritumoral habitat features and clinical-radiologic characteristics to preoperatively predict the STAS status of primary LUAD and further explore the potential biological basis underlying the prediction model. Methods: Conventional radiomics features and habitat features were extracted from intratumoral and peritumoral regions on preoperative computerized tomography (CT) images. A new index, the ITH score, was developed to quantify ITH levels. Univariable and multivariable logistic regression analyses were conducted to identify clinical-radiologic characteristics associated with STAS. Various machine learning algorithms were used to build the prediction models. Additionally, intratumoral-peritumoral habitat features, ITH score, and clinical-radiologic characteristics were integrated into a combined model. Finally, 24 patients with RNA sequencing data were utilized for gene expression analysis. Results: A total of 1268 patients (median age, 60 years; IQR, 53.8–66.0 years; 850 female) were divided into the training set ( n = 943), validation set ( n = 236), and external test set ( n = 89). Using the Light Gradient Boosting Machine classifier, the combined model demonstrated the highest predictive performance for STAS, achieving an AUC value of 0.97 in the training, 0.98 in the validation, and 0.91 in the external test set. Differentially expressed genes in a high combined model probability group were associated with monocarboxylic acid transport and metabolism. Conclusion: The combined model demonstrated superior performance in predicting STAS in patients with primary LUAD.
- 9 December 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (4) , 9213-9224
Open AccessMachine learning-based quantitative prediction of spread through air spaces in primary lung adenocarcinoma using intratumoral heterogeneity scores
Background: Spread through air spaces (STAS) is a distinct, aggressive pattern of primary lung adenocarcinoma (LUAD) that affects both prognosis and treatment strategies for patients. This study aimed to quantify intratumoral heterogeneity (ITH) and integrate the quantitative metrics with intratumoral-peritumoral habitat features and clinical-radiologic characteristics to preoperatively predict the STAS status of primary LUAD and further explore the potential biological basis underlying the prediction model. Methods: Conventional radiomics features and habitat features were extracted from intratumoral and peritumoral regions on preoperative computerized tomography (CT) images. A new index, the ITH score, was developed to quantify ITH levels. Univariable and multivariable logistic regression analyses were conducted to identify clinical-radiologic characteristics associated with STAS. Various machine learning algorithms were used to build the prediction models. Additionally, intratumoral-peritumoral habitat features, ITH score, and clinical-radiologic characteristics were integrated into a combined model. Finally, 24 patients with RNA sequencing data were utilized for gene expression analysis. Results: A total of 1268 patients (median age, 60 years; IQR, 53.8–66.0 years; 850 female) were divided into the training set ( n = 943), validation set ( n = 236), and external test set ( n = 89). Using the Light Gradient Boosting Machine classifier, the combined model demonstrated the highest predictive performance for STAS, achieving an AUC value of 0.97 in the training, 0.98 in the validation, and 0.91 in the external test set. Differentially expressed genes in a high combined model probability group were associated with monocarboxylic acid transport and metabolism. Conclusion: The combined model demonstrated superior performance in predicting STAS in patients with primary LUAD.
- Open Access
- 19 September 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (1) , 314-324
Intratumoral and peritumoral heterogeneity based on CT to predict the pathological response after neoadjuvant chemoimmunotherapy in esophageal squamous cell carcinoma
Background: Neoadjuvant chemoimmunotherapy (NACI) regimen (camrelizumab plus paclitaxel and nedaplatin) has shown promising potential in patients with esophageal squamous cell carcinoma (ESCC), but accurately predicting the therapeutic response remains a challenge. Objective: To develop and validate a CT-based machine learning model that incorporates both intratumoral and peritumoral heterogeneity for predicting the pathological response of ESCC patients after NACI. Methods: Patients with ESCC who underwent surgery following NACI between June 2020 and July 2024 were included retrospectively and prospectively. Univariate and multivariate logistic regression analyses were performed to identify clinical variables associated with pathological response. Traditional radiomics features and habitat radiomics features from the intratumoral and peritumoral regions were extracted from posttreatment CT images, and 6 predictive models were established using 14 machine learning algorithms. The combined model was developed by integrating intratumoral and peritumoral habitat radiomics features with clinical variables. The performance of the models was evaluated using the area under the receiver operating characteristic curve (AUC). Results: A total of 157 patients (mean [SD] age, 59.6 [6.5] years) were enrolled in our study, of whom 60 (38.2%) achieved major pathological response (MPR) and 40 (25.5%) achieved pathological complete response (pCR). The combined model demonstrated excellent predictive ability for MPR after NACI, with an AUC of 0.915 (95% CI: 0.844–0.981), accuracy of 0.872, sensitivity of 0.733, and specificity of 0.938 in the test set. In sensitivity analysis focusing on pCR, the combined model exhibited robust performance, with an AUC of 0.895 (95% CI: 0.782 – 0.980) in the test set. Conclusion: The combined model integrating intratumoral and peritumoral habitat radiomics features with clinical variables can accurately predict MPR in ESCC patients after NACI and shows promising potential in predicting pCR.
- 19 September 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (1) , 314-324
Open AccessIntratumoral and peritumoral heterogeneity based on CT to predict the pathological response after neoadjuvant chemoimmunotherapy in esophageal squamous cell carcinoma
Background: Neoadjuvant chemoimmunotherapy (NACI) regimen (camrelizumab plus paclitaxel and nedaplatin) has shown promising potential in patients with esophageal squamous cell carcinoma (ESCC), but accurately predicting the therapeutic response remains a challenge. Objective: To develop and validate a CT-based machine learning model that incorporates both intratumoral and peritumoral heterogeneity for predicting the pathological response of ESCC patients after NACI. Methods: Patients with ESCC who underwent surgery following NACI between June 2020 and July 2024 were included retrospectively and prospectively. Univariate and multivariate logistic regression analyses were performed to identify clinical variables associated with pathological response. Traditional radiomics features and habitat radiomics features from the intratumoral and peritumoral regions were extracted from posttreatment CT images, and 6 predictive models were established using 14 machine learning algorithms. The combined model was developed by integrating intratumoral and peritumoral habitat radiomics features with clinical variables. The performance of the models was evaluated using the area under the receiver operating characteristic curve (AUC). Results: A total of 157 patients (mean [SD] age, 59.6 [6.5] years) were enrolled in our study, of whom 60 (38.2%) achieved major pathological response (MPR) and 40 (25.5%) achieved pathological complete response (pCR). The combined model demonstrated excellent predictive ability for MPR after NACI, with an AUC of 0.915 (95% CI: 0.844–0.981), accuracy of 0.872, sensitivity of 0.733, and specificity of 0.938 in the test set. In sensitivity analysis focusing on pCR, the combined model exhibited robust performance, with an AUC of 0.895 (95% CI: 0.782 – 0.980) in the test set. Conclusion: The combined model integrating intratumoral and peritumoral habitat radiomics features with clinical variables can accurately predict MPR in ESCC patients after NACI and shows promising potential in predicting pCR.
- Open Access
- 18 July 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (11) , 7746-7760
Molecular characterization of breast cancer and multiple primary malignancies: the latest application using unmarked quantitative proteomics
Background: Breast cancer remains the most prevalent malignancy among women, and patients presenting with both breast and lung cancer pose significant challenges in clinical diagnosis and treatment. Currently, comprehensive multi-omics analyses for such multiple malignancies are lacking. Methods: An integrated multi-omics analysis was performed, incorporating quantitative proteomics and radiomics data from patients with single primary breast cancer as well as those with multiple primary tumors (breast and lung cancer). Results: Quantitative proteomics analysis revealed four distinct molecular signatures (Types I–IV). Patients with single breast cancer exhibited driving pathways primarily linked to cell proliferation (e.g., HER2), whereas those with multiple breast cancers showed enrichment in ER-related and proliferative pathways. In contrast, patients with multiple lung cancers displayed pathways associated with immune response and immune escape. Additionally, immune subtyping identified three distinct immune landscapes (Types I–III). Radiomic analysis demonstrated strong correlations between these molecular/immune subtypes and imaging findings. Patients with high imaging information scores exhibited pronounced tumor heterogeneity and reduced immune infiltration. Conclusions: This study provides new insights into the molecular pathogenesis of multiple primary malignancies, particularly breast and lung cancer.
- 18 July 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (11) , 7746-7760
Open AccessMolecular characterization of breast cancer and multiple primary malignancies: the latest application using unmarked quantitative proteomics
Background: Breast cancer remains the most prevalent malignancy among women, and patients presenting with both breast and lung cancer pose significant challenges in clinical diagnosis and treatment. Currently, comprehensive multi-omics analyses for such multiple malignancies are lacking. Methods: An integrated multi-omics analysis was performed, incorporating quantitative proteomics and radiomics data from patients with single primary breast cancer as well as those with multiple primary tumors (breast and lung cancer). Results: Quantitative proteomics analysis revealed four distinct molecular signatures (Types I–IV). Patients with single breast cancer exhibited driving pathways primarily linked to cell proliferation (e.g., HER2), whereas those with multiple breast cancers showed enrichment in ER-related and proliferative pathways. In contrast, patients with multiple lung cancers displayed pathways associated with immune response and immune escape. Additionally, immune subtyping identified three distinct immune landscapes (Types I–III). Radiomic analysis demonstrated strong correlations between these molecular/immune subtypes and imaging findings. Patients with high imaging information scores exhibited pronounced tumor heterogeneity and reduced immune infiltration. Conclusions: This study provides new insights into the molecular pathogenesis of multiple primary malignancies, particularly breast and lung cancer.
- Open Access
- 29 May 2023
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 149 (12) , 9757-9765
A new nomogram for assessing complete response (CR) in gastric diffuse large B-cell lymphoma (DLBCL) patients after chemotherapy
Purpose: Achieving complete response (CR) after first-line chemotherapy in gastric DLBCL patients often results in longer disease-free survival. We explored whether a model based on imaging features combined with clinicopathological factors could assess the CR to chemotherapy in patients with gastric DLBCL. Methods: Univariate (P < 0.10) and multivariate (P < 0.05) analyses were used to identify factors associated with a CR to treatment. As a result, a system was developed to evaluate whether gastric DLBCL patients had a CR to chemotherapy. Evidence was found to support the model's ability to predict outcomes and demonstrate clinical value. Results: We retrospectively analysed 108 people who had been diagnosed gastric DLBCL; 53 were in CR. Patients were divided at random into a 5:4 training/testing dataset split. β2 microglobulin before and after chemotherapy and lesion length after chemotherapy were independent predictors of the CR of gastric DLBCL patients after chemotherapy. These factors were used in the predictive model construction. In the training dataset, the area under the curve (AUC) of the model was 0.929, the specificity was 0.806, and the sensitivity was 0.862. In the testing dataset, the model had an AUC of 0.957, specificity of 0.792, and sensitivity of 0.958. The AUC did not differ significantly between the training and testing dates (P > 0.05). Conclusion: A model constructed using imaging features combined with clinicopathological factors could effectively evaluate the CR to chemotherapy in gastric DLBCL patients. The predictive model can facilitate the monitoring of patients and be used to adjust individualised treatment plans.
- 29 May 2023
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 149 (12) , 9757-9765
Open AccessA new nomogram for assessing complete response (CR) in gastric diffuse large B-cell lymphoma (DLBCL) patients after chemotherapy
Purpose: Achieving complete response (CR) after first-line chemotherapy in gastric DLBCL patients often results in longer disease-free survival. We explored whether a model based on imaging features combined with clinicopathological factors could assess the CR to chemotherapy in patients with gastric DLBCL. Methods: Univariate (P < 0.10) and multivariate (P < 0.05) analyses were used to identify factors associated with a CR to treatment. As a result, a system was developed to evaluate whether gastric DLBCL patients had a CR to chemotherapy. Evidence was found to support the model's ability to predict outcomes and demonstrate clinical value. Results: We retrospectively analysed 108 people who had been diagnosed gastric DLBCL; 53 were in CR. Patients were divided at random into a 5:4 training/testing dataset split. β2 microglobulin before and after chemotherapy and lesion length after chemotherapy were independent predictors of the CR of gastric DLBCL patients after chemotherapy. These factors were used in the predictive model construction. In the training dataset, the area under the curve (AUC) of the model was 0.929, the specificity was 0.806, and the sensitivity was 0.862. In the testing dataset, the model had an AUC of 0.957, specificity of 0.792, and sensitivity of 0.958. The AUC did not differ significantly between the training and testing dates (P > 0.05). Conclusion: A model constructed using imaging features combined with clinicopathological factors could effectively evaluate the CR to chemotherapy in gastric DLBCL patients. The predictive model can facilitate the monitoring of patients and be used to adjust individualised treatment plans.